Rapid downregulation of LL-37 and β-Defensins in psoriasis with etanercept therapy

被引:0
|
作者
Smith, N. R. [1 ]
Wang, F. [1 ]
Kang, S. [2 ]
Fisher, G. J. [1 ]
Voorhees, J. J. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
111
引用
收藏
页码:S19 / S19
页数:1
相关论文
共 50 条
  • [21] Investigation of the spatiotemporal expression pattern of the antimicrobial peptide, LL-37, in the development and resolution of psoriasis
    Perera, G. K.
    Kassen, D.
    Nestle, F. O.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (04) : 904 - 904
  • [22] Effect of Narrowband Ultraviolet B Therapy on Serum Vitamin D and Cathelicidin (LL-37) in Patients with Chronic Plaque Psoriasis
    Al-Mutairi, Nawaf
    Shaaban, Dalia
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2014, 18 (01) : 43 - 48
  • [23] Measurement of vitamin D and cathelicidin (LL-37) levels in patients of psoriasis with co-morbidities
    Al-Mutairi, Nawaf
    El Eassa, Bayoumi
    Nair, Vasanthy
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 (04): : 492 - 496
  • [24] Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses
    Molhoek, E. Margo
    den Hertog, Alice L.
    de Vries, Anne-Marij B. C.
    Nazmi, Kamran
    Veerman, Enno C. I.
    Hartgers, Franca C.
    Yazdanbakhsh, Maria
    Bikker, Floris J.
    van der Kleij, Desiree
    BIOLOGICAL CHEMISTRY, 2009, 390 (04) : 295 - 303
  • [25] Significance of LL-37 on Immunomodulation and Disease Outcome
    Yang, Binbin
    Good, David
    Mosaiab, Tamim
    Liu, Wei
    Ni, Guoying
    Kaur, Jasmine
    Liu, Xiaosong
    Jessop, Calvin
    Yang, Lu
    Fadhil, Rushdi
    Yi, Zhengjun
    Wei, Ming Q.
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [26] Vitamin D and LL-37 in children with pneumonia
    Albanna, Ehab A. M.
    Ali, Yasser F.
    Elkashnia, Reayid A. M.
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 8 (02): : 81 - 86
  • [27] Carbamylated LL-37 as a modulator of the immune response
    Koro, Catalin
    Hellvard, Annelie
    Delaleu, Nicolas
    Binder, Veronika
    Scavenius, Carsten
    Bergum, Brith
    Glowczyk, Izabela
    Roberts, Helen M.
    Chapple, Iain L. C.
    Grant, Melissa M.
    Rapala-Kozik, Maria
    Klaga, Kinga
    Enghild, Jan J.
    Potempa, Jan
    Mydel, Piotr
    INNATE IMMUNITY, 2016, 22 (03) : 218 - 229
  • [28] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [29] Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
    Lu, Fatai
    Zhu, Yingkang
    Zhang, Guodong
    Liu, Zunpeng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] The Role of Cathelicidin LL-37 in Cancer Development
    Piktel, Ewelina
    Niemirowicz, Katarzyna
    Wnorowska, Urszula
    Watek, Marzena
    Wollny, Tomasz
    Gluszek, Katarzyna
    Gozdz, Stanislaw
    Levental, Ilya
    Bucki, Robert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (01) : 33 - 46